Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Depreciation and Depletion (2018 - 2023)

Historic Depreciation and Depletion for Viemed Healthcare (VMD) over the last 6 years, with Q3 2023 value amounting to $6.0 million.

  • Viemed Healthcare's Depreciation and Depletion rose 4498.91% to $6.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.3 million, marking a year-over-year increase of 4130.9%. This contributed to the annual value of $15.6 million for FY2022, which is 3817.19% up from last year.
  • Latest data reveals that Viemed Healthcare reported Depreciation and Depletion of $6.0 million as of Q3 2023, which was up 4498.91% from $5.2 million recorded in Q2 2023.
  • In the past 5 years, Viemed Healthcare's Depreciation and Depletion registered a high of $6.0 million during Q3 2023, and its lowest value of $1.3 million during Q2 2019.
  • For the 5-year period, Viemed Healthcare's Depreciation and Depletion averaged around $3.1 million, with its median value being $2.8 million (2020).
  • In the last 5 years, Viemed Healthcare's Depreciation and Depletion surged by 7067.9% in 2019 and then surged by 997.53% in 2021.
  • Viemed Healthcare's Depreciation and Depletion (Quarter) stood at $2.0 million in 2019, then soared by 41.71% to $2.8 million in 2020, then grew by 9.98% to $3.1 million in 2021, then skyrocketed by 40.16% to $4.4 million in 2022, then surged by 36.63% to $6.0 million in 2023.
  • Its last three reported values are $6.0 million in Q3 2023, $5.2 million for Q2 2023, and $4.8 million during Q1 2023.